Phase 4 Type 2 Diabetes Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults aged 19 or older who have been diagnosed with diabetes
• People whose carotid ultrasound (a scan of the neck arteries) showed a wall thickness measurement of 1.0mm or more
• People who have not made any changes to their combination of medications — including diabetes, blood pressure, or cholesterol medicines — in the past three months
• People whose HbA1c blood sugar level (a measure of average blood sugar over time) is 10% or less
• People who have willingly agreed to take part and signed a consent form

Who may not be able to join:

• People currently taking blood-thinning or clot-preventing medications, other than aspirin
• People who have a bleeding disorder or a condition that may increase the risk of bleeding, such as hemophilia, fragile blood vessels, brain bleeding, stomach bleeding, blood in the urine, or eye bleeding (confirm with trial site)
• People with an active stomach ulcer, a bleeding stroke in the past 6 months, surgery in the past 3 months, advanced diabetic eye disease, or uncontrolled high blood pressure
• People who have had a stroke, mini-stroke, heart attack, unstable chest pain, or a heart procedure (such as bypass surgery or a stent) in the past 6 months
• People with severe kidney or liver disease
• People with heart failure
• People who have had an allergic reaction to the study drug or any of its ingredients
• Women who are pregnant or think they may be pregnant
• Women who are breastfeeding or plan to breastfeed during the study

Important: Always verify eligibility with the trial site directly before applying.